a therapeutically focused leader in research-based drug development, medpace builds strong strategic partnerships with select sponsors to advance the most efficient and cost-effective path to drug approval. as a full service, global clinical research organization (cro), medpace sees itself as a steward of your drug, leveraging its extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial. from custom solutions addressing the needs of small and midsize biotechnology companies to full-service offerings for global pharmaceutical companies, medpace has the breadth, depth, and flexibility to deliver a superior result, specific to your needs, on six continents.
Company profile
Ticker
MEDP
Exchange
CEO
August Troendle
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Syneos Health • Icon • Incyte • Zymergen • OmniAb • SomaLogic ...
SEC CIK
Corporate docs
Subsidiaries
Delaware Medpace Acquisition, Inc. • Delaware Medpace IntermediateCo, Inc. • Ohio Imagepace, LLC • Ohio Medpace Clinical Pharmacology LLC • Ohio Medpace, Inc. • Ohio Medpace Reference Laboratories LLC ...
MEDP stock data
Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
3 Apr 24
DEF 14A
Definitive proxy
3 Apr 24
ARS
2023 FY
Annual report to shareholders
3 Apr 24
8-K
Entry into a Material Definitive Agreement
29 Mar 24
PRE 14A
Preliminary proxy
20 Mar 24
10-K
2023 FY
Annual report
13 Feb 24
8-K
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Results
12 Feb 24
10-Q
2023 Q3
Quarterly report
24 Oct 23
8-K
Medpace Holdings, Inc. Reports Third Quarter 2023 Results
23 Oct 23
10-Q
2023 Q2
Quarterly report
25 Jul 23
Transcripts
MEDP
Earnings call transcript
2023 Q4
13 Feb 24
MEDP
Earnings call transcript
2023 Q3
24 Oct 23
MEDP
Earnings call transcript
2023 Q2
25 Jul 23
MEDP
Earnings call transcript
2023 Q1
25 Apr 23
MEDP
Earnings call transcript
2022 Q4
14 Feb 23
MEDP
Earnings call transcript
2022 Q3
25 Oct 22
MEDP
Earnings call transcript
2022 Q2
26 Jul 22
MEDP
Earnings call transcript
2022 Q1
26 Apr 22
MEDP
Earnings call transcript
2021 Q4
15 Feb 22
MEDP
Earnings call transcript
2021 Q3
26 Oct 21
Latest ownership filings
4
Robert O. Kraft
2 Apr 24
4
Cornelius P. McCarthy III
2 Apr 24
4
Brian T Carley
2 Apr 24
4
SUSAN E BURWIG
19 Mar 24
4
Ashley M. Keating
18 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
4
August J. Troendle
8 Mar 24
4
Change in insider ownership
8 Mar 24
SC 13D/A
Troendle August J.
8 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 478 |
Opened positions | 77 |
Closed positions | 49 |
Increased positions | 149 |
Reduced positions | 181 |
13F shares | Current |
---|---|
Total value | 5.56 tn |
Total shares | 39.47 mm |
Total puts | 50.90 k |
Total calls | 64.10 k |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
Cinven Capital Management | 10.40 mm | $451.26 mm |
Troendle August J. | 5.91 mm | $1.51 bn |
Vanguard | 2.41 mm | $584.47 bn |
BLK Blackrock | 2.38 mm | $576.30 bn |
Wasatch Advisors | 1.27 mm | $307.95 bn |
STT State Street | 645.86 k | $156.38 bn |
Fuller & Thaler Asset Management | 638.45 k | $154.59 bn |
IVZ Invesco | 611.90 k | $148.16 bn |
Riverbridge Partners | 609.19 k | $147.50 bn |
Boston Trust Walden | 539.96 k | $130.74 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar 24 | Carley Brian T | Common Stock | Option exercise | Acquire M | No | No | 0 | 79 | 0.00 | 21,674 |
31 Mar 24 | Carley Brian T | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 79 | 0.00 | 234 |
31 Mar 24 | Kraft Robert O. | Common Stock | Option exercise | Acquire M | No | No | 0 | 72 | 0.00 | 448 |
31 Mar 24 | Kraft Robert O. | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 72 | 0.00 | 214 |
31 Mar 24 | McCarthy Cornelius P. III | Common Stock | Option exercise | Acquire M | No | No | 0 | 63 | 0.00 | 5,101 |
31 Mar 24 | McCarthy Cornelius P. III | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 63 | 0.00 | 186 |
15 Mar 24 | Susan E Burwig | Common Stock | Sell | Dispose S | No | No | 403 | 102 | 41.11 k | 15,181 |
14 Mar 24 | Keating Ashley M. | Common Stock | Sell | Dispose S | No | No | 409.87 | 250 | 102.47 k | 250 |
14 Mar 24 | Keating Ashley M. | Common Stock | Option exercise | Acquire M | No | No | 84.36 | 500 | 42.18 k | 500 |
14 Mar 24 | Keating Ashley M. | Stock Option Common Stock | Option exercise | Dispose M | No | No | 84.36 | 500 | 42.18 k | 3,358 |
News
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $6,800 Today
11 Apr 24
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $6,500 Today
2 Apr 24
12 Health Care Stocks Moving In Friday's After-Market Session
29 Mar 24
Deutsche Bank Initiates Coverage On Medpace Hldgs with Hold Rating, Announces Price Target of $395
18 Mar 24
$100 Invested In This Stock 5 Years Ago Would Be Worth $700 Today
13 Mar 24